Reuters logo
BRIEF-Corcept Therapeutic says Dohmen Life Science Services filed a complaint alleging Corcept unlawfully terminated Dohmen agreement
August 30, 2017 / 1:10 PM / 3 months ago

BRIEF-Corcept Therapeutic says Dohmen Life Science Services filed a complaint alleging Corcept unlawfully terminated Dohmen agreement

Aug 30 (Reuters) - Corcept Therapeutics Inc

* Corcept Therapeutics Inc - On August 7, 2017, Dohmen Life Science Services filed a complaint alleging corcept unlawfully terminated dohmen agreement

* Corcept Therapeutics - Dohmen has since informed Corcept that it is withholding cash payments it collects from sale of Korlym that Dohmen is obligated to pay

* Corcept Therapeutics Inc - These cash and receivables total approximately $13.2 million.

* Corcept Therapeutics Inc - Dohmen has stated that it will remit to Corcept any balance in excess of its calculation of such damages.

* Corcept Therapeutics - On August 29, corcept filed complaint against Dohmen alleging fraudulent inducement, negligent misrepresentation, breach of contract

* Corcept Therapeutics - Immediately following Dohmen's cessation of services under agreement, Corcept began serving Korlym patients through another specialty pharmacy Source text: [bit.ly/2vrT47s] Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below